Choueiri, T. K., Merchan, J. R., Patnaik, A., Drakaki, A., Rini, B. I., Rha, S. Y., Lee, J. L., Ornstein, M. C., Kumar, R., Hwang, C., Shao, Y. F., Park, S. H., Barata, P. C., Chen, J., Weeder, B., Cole, H., Warad, D. M., Foster, P. G., Guan, Y., McKay, R. R. (2026). Activity and biomarker analyses with casdatifan (cas), a next-generation HIF-2α inhibitor, in refractory clear cell renal cell carcinoma (ccRCC): Results from ARC-20.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.493